Application of ICOS<+>CXCR3<+> regulatory T cells in preparation of medicine for preventing severe pneumonia

A technology for severe pneumonia and regulation, applied in the field of biomedicine, can solve the problems such as disputes in the adjuvant treatment of severe pneumonia, and achieve the effect of good prevention and protection, high degree of technology promotion, and avoidance of side effects.

Inactive Publication Date: 2020-01-31
NANJING DRUM TOWER HOSPITAL
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, although hormones have powerful anti-inflammatory effects, they are still controversial as an adjuvant therapy for severe pneumonia.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of ICOS&lt;+&gt;CXCR3&lt;+&gt; regulatory T cells in preparation of medicine for preventing severe pneumonia
  • Application of ICOS&lt;+&gt;CXCR3&lt;+&gt; regulatory T cells in preparation of medicine for preventing severe pneumonia
  • Application of ICOS&lt;+&gt;CXCR3&lt;+&gt; regulatory T cells in preparation of medicine for preventing severe pneumonia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] ICOS + CXCR3 + In vitro isolation and expansion of regulatory T cells

[0026] 1. ICOS + CXCR3 + Isolation of regulatory T cells

[0027] Step 1: Separating mouse spleen mononuclear cells to obtain mouse spleen mononuclear cell suspension. The specific process is:

[0028] 1) Preparation of materials and reagents: mouse dissecting instruments, 75% alcohol, sterile PBS buffer, complete mouse spleen and lung cell culture medium (RPMI1640 medium with 10% calf serum), erythrocyte lysate, 200 mesh nylon membrane.

[0029] 2) Mice were killed by dislocation of the cervical spine, soaked in 75% alcohol for 10 minutes for disinfection, taken out and fixed on the mouse dissecting board.

[0030] 3) Use ophthalmic scissors to cut from the perineum of the mouse and draw it to the head, peel off the outer skin and fix it, cut the incision at the abdominal capsule, take out the spleen with ophthalmic scissors and tweezers, add an appropriate amount of pre-cooled PBS buffer, a...

Embodiment 2

[0055] ICOS + CXCR3 + Administration of regulatory T cells

[0056] 1. Final identification before use

[0057] 1. Sterility test

[0058] If there is no abnormality during the culture process, the ICOS + CXCR3 + Two days before the regulatory T cells were infused into the mice, after the last medium change, a sterility test was performed on the supernatant in each culture dish, and bacteria and mold were cultured. The cell supernatant must not have bacteria and mold growth.

[0059] 2. Appearance and observation under the microscope

[0060] On the day of infusion, if the sterility test reports no growth of bacteria or mold, observe the color of the supernatant in the petri dish, observe the cell shape, cell density, and whether there is growth of bacteria or mold under an inverted microscope. If there is any doubt, another sample must be taken for sterility test to cultivate bacteria and mold.

[0061] 3. Proportion of living cells

[0062] On the day of infusion, sam...

Embodiment 3

[0079] ICOS + CXCR3 + Application of regulatory T cells in the preparation of drugs for preventing severe bacterial pneumonia animal models

[0080] 1. Preparation of bacteria solution for Haemophilus influenzae infection

[0081] 1) Take out the Haemophilus influenzae NT127 frozen at -80°C, dip a little with a sterilized wooden stick, inoculate it on the sBHI culture plate by streaking, and cultivate overnight in a carbon dioxide incubator at 37°C.

[0082] 2) Pick multiple single colonies and inoculate them in 10 ml of sBHI liquid medium, culture on a shaker at 37° C. at 130 rpm until OD600 = 0.4-0.5.

[0083] 3), room temperature, 4000rpm, centrifuge for 15 minutes, collect bacteria.

[0084] 4) Bacteria were resuspended in 12ml of PBS buffer, centrifuged at 4000rpm at room temperature for 15 minutes, and the bacteria were collected. Resuspend in PBS buffer, adjust OD600=1.0, at this time the bacterial concentration is about 3×109CFU / ml.

[0085] 5), 10-fold gradient d...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an application of ICOS<+>CXCR3<+> regulatory T cells in the preparation of a medicine for preventing severe pneumonia. The medicine for preventing the pneumonia includes the ICOS<+>CXCR3<+> regulatory T cells and a pharmaceutically acceptable carrier. The medicine has the advantages of a good prevention and protection effect, long duration time and the like.

Description

technical field [0001] The invention belongs to the field of biomedicine, in particular to an ICOS + CXCR3 + Application of regulatory T cells in the preparation of drugs for the prevention of severe pneumonia. Background technique [0002] Severe pneumonia is a progressive lung inflammation that can rapidly evolve from local infection to systemic infection, severe sepsis, septic shock, and multiple organ dysfunction syndrome (MODS). Among all hospitalized pneumonia patients, 10%-20% are severe pneumonia patients who need to be admitted to the intensive care unit for treatment. Due to the high fatality rate of the disease, the treatment of severe pneumonia has always been a hot spot in academic research. Studies have shown that most of the deaths of pneumonia patients occurred after bacterial clearance, suggesting that anti-infection treatment alone is not enough to reduce the mortality of pneumonia patients. The reason may be that a series of immune responses caused by ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K35/17A61P11/00C12N5/0783
CPCA61K35/17A61P11/00C12N5/0637C12N2500/02C12N2500/32C12N2500/44C12N2500/84C12N2501/2302C12N2509/00
Inventor 孙凌云李文超陈纬纬
Owner NANJING DRUM TOWER HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap